Literature DB >> 17716355

Essential pathogenic and metabolic differences in steatosis induced by choline or methione-choline deficient diets in a rat model.

Reeta Veteläinen1, Arlène van Vliet, Thomas M van Gulik.   

Abstract

BACKGROUND AND AIM: Choline deficient (CD) and methione-choline deficient (MCD) diets are rodent models for steatosis, with potentially dissimilar biochemical backgrounds. The aim of this study was to assess the metabolic and pathological derangements in rats fed CD and MCD diets.
METHODS: Male Wistar rats received CD or MCD diet up to 7 weeks. Nutritional status, liver histopathology, Kupffer cell-mediated inflammation and injury, oxidative stress via thiobarbituric reactive species (TBARS), hepatic and plasma glutathione (GSH) and insulin homeostasis were assessed.
RESULTS: In CD-fed rats, mainly microvesicular steatosis developed with occasional inflammatory cells. In MCD-fed rats, macrovesicular steatosis progressed to steatohepatitis (collagen deposition, activated stellate cells). Hepatic TBARS was increased and GSH decreased in the MCD-fed rats compared to no changes in the CD-fed rats. The CD-fed rats developed obesity, dyslipidemia and insulin resistance, in contrast to undetectable plasma lipids, unaffected insulin homeostasis and loss of body weight in the MCD-fed rats.
CONCLUSIONS: The CD diet induced uncomplicated steatosis as compared to progressive inflammation and fibrinogenesis in the MCD diet. CD and MCD diets represent two pathogenically different models of steatosis. Although equivalence for the outcome of both diets can be found in clinical steatosis, the results of models using these diets should be compared with caution.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17716355     DOI: 10.1111/j.1440-1746.2006.04701.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  33 in total

1.  Impaired de novo choline synthesis explains why phosphatidylethanolamine N-methyltransferase-deficient mice are protected from diet-induced obesity.

Authors:  René L Jacobs; Yang Zhao; Debby P Y Koonen; Torunn Sletten; Brian Su; Susanne Lingrell; Guoqing Cao; David A Peake; Ming-Shang Kuo; Spencer D Proctor; Brian P Kennedy; Jason R B Dyck; Dennis E Vance
Journal:  J Biol Chem       Date:  2010-05-07       Impact factor: 5.157

2.  Dietary supplementation with methyl donors reduces fatty liver and modifies the fatty acid synthase DNA methylation profile in rats fed an obesogenic diet.

Authors:  P Cordero; A M Gomez-Uriz; J Campion; F I Milagro; J A Martinez
Journal:  Genes Nutr       Date:  2012-05-31       Impact factor: 5.523

3.  Hepatic injury due to combined choline-deprivation and thioacetamide administration: an experimental approach to liver diseases.

Authors:  Hussam Al-Humadi; Stamatios Theocharis; Ismene Dontas; Vasileios Stolakis; Apostolos Zarros; Argyro Kyriakaki; Rafal Al-Saigh; Charis Liapi
Journal:  Dig Dis Sci       Date:  2012-07-10       Impact factor: 3.199

Review 4.  GC-1: A Thyromimetic With Multiple Therapeutic Applications in Liver Disease.

Authors:  Amedeo Columbano; Grazia Chiellini; Marta Anna Kowalik
Journal:  Gene Expr       Date:  2017-06-13

5.  The effect of hepatic ischemia reperfusion injury in a murine model of nonalcoholic steatohepatitis.

Authors:  Amit D Tevar; Callisia N Clarke; Rebecca Schuster; Jiang Wang; Michael J Edwards; Alex B Lentsch
Journal:  J Surg Res       Date:  2011-03-02       Impact factor: 2.192

6.  MCD diet-induced steatohepatitis is associated with alterations in asymmetric dimethylarginine (ADMA) and its transporters.

Authors:  Laura G Di Pasqua; Clarissa Berardo; Vittoria Rizzo; Plinio Richelmi; Anna Cleta Croce; Mariapia Vairetti; Andrea Ferrigno
Journal:  Mol Cell Biochem       Date:  2016-06-29       Impact factor: 3.396

7.  Experimental models of non-alcoholic fatty liver disease in rats.

Authors:  Otto Kucera; Zuzana Cervinkova
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

8.  Aerobic exercise training in the treatment of non-alcoholic fatty liver disease related fibrosis.

Authors:  Melissa A Linden; Ryan D Sheldon; Grace M Meers; Laura C Ortinau; E Matthew Morris; Frank W Booth; Jill A Kanaley; Victoria J Vieira-Potter; James R Sowers; Jamal A Ibdah; John P Thyfault; M Harold Laughlin; R Scott Rector
Journal:  J Physiol       Date:  2016-05-27       Impact factor: 5.182

9.  Influence of Kupffer cells and platelets on ischemia-reperfusion injury in mild steatotic liver.

Authors:  Koichi Ogawa; Tadashi Kondo; Takafumi Tamura; Hideki Matsumura; Kiyoshi Fukunaga; Tatsuya Oda; Nobuhiro Ohkohchi
Journal:  World J Gastroenterol       Date:  2013-03-07       Impact factor: 5.742

10.  Obesity induced by a pair-fed high fat sucrose diet: methylation and expression pattern of genes related to energy homeostasis.

Authors:  Almudena Lomba; Fermín I Milagro; Diego F García-Díaz; Amelia Marti; Javier Campión; J Alfredo Martínez
Journal:  Lipids Health Dis       Date:  2010-06-09       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.